Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
The Neuronal Ceroid Lipofuscinosis 10 (NCL10) DNA test in dogs is essential for early detection of this inherited neurodegenerative disorder. NCL10 affects the nervous system, leading to progressive neurological decline and reduced quality of life. By using a simple DNA test, breeders and veterinarians can identify carriers and affected dogs, helping to prevent the spread of this fatal condition. Early diagnosis through the NCL10 DNA test enables better management and informed breeding decisions. This genetic screening is crucial for maintaining healthy dog populations and promoting responsible breeding practices. Ensure your dog’s health with the reliable NCL10 DNA test today. Protect your pets from hereditary diseases with advanced genetic testing.
The DNA test for Neuronal Ceroid Lipofuscinosis 10 (NCL10) in dogs helps identify carriers and affected individuals of this inherited neurodegenerative disorder. NCL10 leads to progressive neurological decline, causing symptoms like vision loss, seizures, and motor dysfunction. Early genetic testing enables breeders to make informed decisions to reduce the incidence of the disease. This test is especially important in breeds known to carry the NCL10 mutation. By using DNA testing, the health and quality of life of future generations can be improved.
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Neuronal Ceroid Lipofuscinosis 10 (NCL10) is a progressive neurodegenerative disorder that affects the central nervous system of dogs. It is classified as a lysosomal storage disease, which means that it results from the accumulation of certain proteins and lipids within the cells, leading to cellular dysfunction and death. This condition is caused by mutations in the CLN5 gene, which plays a crucial role in cellular metabolism and waste processing.
The symptoms of NCL10 typically manifest in young dogs, usually between the ages of 6 months and 3 years. Initial signs may include behavioral changes, such as increased anxiety and irritability, as well as problems with coordination and balance. As the disease progresses, dogs may experience vision problems, seizures, and cognitive decline. Eventually, the condition can lead to severe neurological impairment and, ultimately, a decline in quality of life.
Diagnosis of Neuronal Ceroid Lipofuscinosis 10 is primarily based on clinical observation and genetic testing. Veterinarians may suspect NCL10 based on the dog's symptoms and family history. A definitive diagnosis can be made through DNA testing, which identifies mutations in the CLN5 gene associated with this condition. Early diagnosis is crucial for managing the disease and making informed decisions regarding treatment options and care.
Currently, there is no cure for Neuronal Ceroid Lipofuscinosis 10, and treatment options are largely supportive. Management focuses on alleviating symptoms and improving the quality of life for affected dogs. This may include physical therapy, dietary adjustments, and medications to manage seizures or other symptoms. Regular veterinary check-ups are essential to monitor the progression of the disease and make necessary adjustments to the care plan.
Genetic testing for NCL10 is vital for breeders and dog owners to understand the genetic risks associated with this condition. By identifying carrier dogs and affected individuals, responsible breeding practices can be implemented to reduce the incidence of NCL10 in future generations. Additionally, genetic testing can provide valuable information for pet owners regarding the health of their dogs and help in making informed decisions about their care.
Neuronal Ceroid Lipofuscinosis 10 is a serious genetic disorder that poses significant challenges for affected dogs and their owners. Understanding the condition, its symptoms, and the importance of genetic testing can empower pet owners to take proactive steps in managing their dog's health. While there is no cure, early diagnosis and supportive care can help improve the quality of life for dogs suffering from this debilitating disease.
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
This DNA test detects the mutation associated with Neuronal Ceroid Lipofuscinosis 10 (NCL10) in order to identify clear, carrier, or at-risk animals.
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
This test analyses the mutation CTSD c.597G>A.
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Awano Tomoyuki, Katz Martin L, O'Brien Dennis P, Taylor Jeremy F, Evans Jason, Khan Shahnawaz, Sohar Istvan, Lobel Peter, Johnson Gary S. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. Mol Genet Metab. 2006 Apr;87(4):341-8. doi: 10.1016/j.ymgme.2005.11.005. Epub 2006 Jan 4.
Bo privasidat, bo eskoho
Nos ta usa kuki esensial pa manehá e wèpsait. Kuki opshonal (manera dunadónan di kontenido inkorporá) ta desabilitá pa default i ta wòrdu aktivá solamente si bo ta di akuerdo. Bo por kambia bo eskoho na kualke momento usando e boton “Cookies”.
Ta nesesario pa karakterístikanan prinsipal i seguridat. Semper aktivá.
Ta mehorá funshonnan manera sparmentu di preferensia òf inkorporashon no-propaganda.
Yuda nos komprondé e uso di e wèpsait. Deshabilitá pa default.
Propaganda/tracking atraves di wèpsaitnan (algun video/mapa ta inkorporá). Deshabilitá pa default.